Eloxx Pharmaceuticals Inc (Eloxx Pharmaceuticals Inc (ELOX) is up Monday morning, with the stock adding 3.70% in pre-market trading to 1.4.
ELOX's short-term technical score of 4 indicates that the stock has traded less bullishly over the last month than 96% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, the stock ranks higher than 10% of stocks.
Eloxx Pharmaceuticals Inc has fallen 46.85% over the past month, closing at $2.30 on April 19. During this period of time, the stock fell as low as $1.35 and as high as $2.59. ELOX has an average analyst recommendation of Buy. The company has an average price target of $4.50.
Eloxx Pharmaceuticals Inc has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 142 by this metric, ELOX ranks better than 1% of stocks.
Important Dates for Investors in ELOX:
-Eloxx Pharmaceuticals Inc is set to release earnings on 8/5/2021. During their last earnings release the company posted EPS of $-0.73. -We do not have a set dividend date for Eloxx Pharmaceuticals Inc at this time. Click Here to get the full Stock Score Report on Eloxx Pharmaceuticals Inc (ELOX) Stock.